Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 2
1988 5
1989 1
1990 4
1991 8
1992 5
1993 11
1994 22
1995 19
1996 20
1997 29
1998 25
1999 26
2000 41
2001 34
2002 28
2003 21
2004 20
2005 8
2006 14
2007 11
2008 2
2009 3
2010 1
2011 2
2012 5
2013 2
2015 1
2016 2
2017 3
2018 2
2019 8
2020 4
2021 4
2022 3
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

386 results

Results by year

Filters applied: . Clear all
Page 1
Infliximab maintenance therapy for fistulizing Crohn's disease.
Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Sands BE, et al. Among authors: van deventer sj. N Engl J Med. 2004 Feb 26;350(9):876-85. doi: 10.1056/NEJMoa030815. N Engl J Med. 2004. PMID: 14985485 Free article. Clinical Trial.
Tytgat GN, van Deventer SJ. Tytgat GN, et al. Among authors: van deventer sj. Int J Colorectal Dis. 1988 Nov;3(4):226-8. doi: 10.1007/BF01660720. Int J Colorectal Dis. 1988. PMID: 3058838 Review. No abstract available.
Molecular interactions shaping the tetraspanin web.
van Deventer SJ, Dunlock VE, van Spriel AB. van Deventer SJ, et al. Biochem Soc Trans. 2017 Jun 15;45(3):741-750. doi: 10.1042/BST20160284. Biochem Soc Trans. 2017. PMID: 28620035 Review.
Immunotherapy of Crohn's disease.
Van Deventer SJ. Van Deventer SJ. Scand J Immunol. 2000 Jan;51(1):18-22. doi: 10.1046/j.1365-3083.2000.00657.x. Scand J Immunol. 2000. PMID: 10632971 Free article. Review.
Intestinal endotoxemia. Clinical significance.
van Deventer SJ, ten Cate JW, Tytgat GN. van Deventer SJ, et al. Gastroenterology. 1988 Mar;94(3):825-31. doi: 10.1016/0016-5085(88)90261-2. Gastroenterology. 1988. PMID: 3276576 Review. No abstract available.
Immunotherapy of Crohn's disease.
van Montfrans C, Camoglio L, van Deventer SJ. van Montfrans C, et al. Among authors: van deventer sj. Mediators Inflamm. 1998;7(3):149-52. doi: 10.1080/09629359891063. Mediators Inflamm. 1998. PMID: 9705600 Free PMC article. Review.
Endoscopy in inflammatory bowel diseases.
Hommes DW, van Deventer SJ. Hommes DW, et al. Among authors: van deventer sj. Gastroenterology. 2004 May;126(6):1561-73. doi: 10.1053/j.gastro.2004.03.023. Gastroenterology. 2004. PMID: 15168367 Review.
Neutrophil adhesion molecules and MOF.
van Deventer SJ, Pajkrt D. van Deventer SJ, et al. Intensive Care Med. 1997 May;23(5):487-8. doi: 10.1007/s001340050362. Intensive Care Med. 1997. PMID: 9201518 No abstract available.
Anti-TNF antibody treatment of Crohn's disease.
van Deventer SJ. van Deventer SJ. Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I114-20. doi: 10.1136/ard.58.2008.i114. Ann Rheum Dis. 1999. PMID: 10577987 Free PMC article. Review. No abstract available.
Cyclooxygenase-dependent signalling: molecular events and consequences.
Versteeg HH, van Bergen en Henegouwen PM, van Deventer SJ, Peppelenbosch MP. Versteeg HH, et al. Among authors: van deventer sj. FEBS Lett. 1999 Feb 19;445(1):1-5. doi: 10.1016/s0014-5793(99)00105-2. FEBS Lett. 1999. PMID: 10069362 Free article. Review.
386 results